Component: Page-footer inline offer cards (3-card layout)
Tracking: location: page-footer, type: inline
Period: Dec 4, 2025 – Mar 4, 2026 (90 days)
Date Pulled: March 4, 2026
Source: Mixpanel (Project ID: 2184552)
Filters: Production traffic only (www.asbestos.com), China excluded
Sitewide Summary
| Metric |
90-Day Total |
| Impressions |
126,627 |
| Clicks |
1,294 |
| CTR |
1.02% |
Weekly Trend
| Period |
Avg Impressions/wk |
Avg Clicks/wk |
CTR |
| Dec |
9,493 |
123 |
1.30% |
| Jan |
8,849 |
104 |
1.17% |
| Feb |
9,943 |
60 |
0.60% |
CTR declined ~55% from Dec to Feb while impressions held steady — indicating growing banner blindness.
Clicks by Offer (Sitewide, 90 Days)
| Offer |
Clicks |
Share |
| /find-an-attorney/ |
324 |
25.0% |
| /clinical-trials/?content=immunotherapy |
196 |
15.1% |
| /webinars/ |
137 |
10.6% |
| /mesothelioma-packet/ |
114 |
8.8% |
| /mesothelioma-packet/?content=legal |
84 |
6.5% |
| /exercise-guide/ |
69 |
5.3% |
| /clinical-trials/ |
64 |
4.9% |
| /mesothelioma-packet/?content=treatment |
44 |
3.4% |
| /financial-assistance/?content=trust-fund |
40 |
3.1% |
| /mesothelioma-care-kit/ |
36 |
2.8% |
| /va-claim/ |
33 |
2.5% |
| /webinars/mesothelioma-veterans-benefits/ |
25 |
1.9% |
| /doctor-match/ |
25 |
1.9% |
| /nutrition-guide/ |
29 |
2.2% |
| All others |
74 |
5.7% |
Peritoneal Page (/mesothelioma/peritoneal/)
| Offer Card |
Impressions |
Clicks |
CTR |
| /find-an-attorney/ |
430 |
10 |
2.3% |
| /clinical-trials/?content=immunotherapy |
396 |
8 |
2.0% |
| /financial-assistance/?content=trust-fund |
195 |
9 |
4.6% |
| /webinars/ |
181 |
0 |
0.0% |
| /exercise-guide/ (removed Dec) |
81 |
1 |
1.2% |
| Total |
1,283 |
28 |
2.2% |
Lead Quality Funnel (Sitewide, 30-Day Conversion Window)
| Step |
Users |
Step Conv |
Overall Conv |
| Footer Click |
1,165 |
— |
100% |
| Form Submit |
32 |
2.75% |
2.75% |
| Lead |
23 |
71.9% |
1.97% |
| MQL |
6 |
26.1% |
0.52% |
| SQL |
2 |
33.3% |
0.17% |
(Funnel uses unique users — 1,165 vs. 1,294 total click events)
Per-Offer Funnel Breakdown
| Offer |
Clickers |
Form Submits |
Leads |
MQLs |
Click-to-Lead |
Click-to-MQL |
| /find-an-attorney/ |
319 |
10 |
5 |
1 |
1.6% |
0.3% |
| /clinical-trials/?content=immunotherapy |
192 |
2 |
1 |
1 |
0.5% |
0.5% |
| /webinars/ |
136 |
0 |
0 |
0 |
0% |
0% |
| /mesothelioma-packet/ |
107 |
10 |
9 |
0 |
8.4% |
0% |
| /mesothelioma-packet/?content=legal |
84 |
0 |
0 |
0 |
0% |
0% |
| /mesothelioma-packet/?content=treatment |
43 |
2 |
2 |
2 |
4.7% |
4.7% |
| /financial-assistance/?content=trust-fund |
40 |
1 |
1 |
1 |
2.5% |
2.5% |
| /va-claim/ |
33 |
— |
— |
— |
— |
— |
Verdict
The component is producing minimal qualified pipeline. Borderline value.
- 2 SQLs from 1,165 unique clickers over 90 days (~1 SQL/month)
- 6 total MQLs — half from low-volume offers (treatment packet: 2, trust fund: 1)
- The highest-click offer (find-an-attorney, 319 clicks) produced only 1 MQL
- Webinars and legal packet are dead weight — 220 combined clicks, zero conversions at any stage
- Treatment packet has best quality (4.7% click-to-MQL) but only 43 clicks total
- Mesothelioma packet (generic) generates leads (8.4%) but they don't qualify — info-seekers, not pipeline
- CTR is trending down (1.3% to 0.6%), suggesting increasing banner blindness
Recommendation
The component isn't worthless (~1 SQL/month), but the declining engagement trend and low pipeline output suggest it may not justify the real estate long-term. Consider:
1. Removing dead-weight cards (webinars, legal packet) and testing higher-converting offers
2. Redesigning the component if the CTR decline continues
3. Evaluating whether the SQL value justifies keeping the component vs. using the space differently